Figure 1.

Study design and flow of participants. IC, informed consent; OLP, open-label placebo; PMS, premenstrual syndrome; TAU, treatment as usual.

Study design and flow of participants. IC, informed consent; OLP, open-label placebo; PMS, premenstrual syndrome; TAU, treatment as usual.